secwatch / observer
8-K filed March 17, 2025, 7:59 PM ET ticker COLL CIK 0001267565
leadership confidence high sentiment neutral materiality 0.60

Collegium nominates Carlos Paya; founder Heffernan retires as Chairman, Santini named; appoints David Dieter as GC

COLLEGIUM PHARMACEUTICAL, INC

item 5.02item 8.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Carlos Paya

Director
COLL · COLLEGIUM PHARMACEUTICAL, INC
Filed
March 17, 2025, 7:59 PM ET
approved the nomination of Dr. Carlos Paya to stand for election
Departed

Gwen Melincoff

Director
COLL · COLLEGIUM PHARMACEUTICAL, INC
Filed
March 17, 2025, 7:59 PM ET
Gwen Melincoff also advised the Board that she will not stand for re-election at the Annual Meeting and will retire from the Board at that time.
Departed

Michael Heffernan

Chairman of the Board
COLL · COLLEGIUM PHARMACEUTICAL, INC
Successor
Gino Santini
Filed
March 17, 2025, 7:59 PM ET
Michael Heffernan, R.Ph., founder and current Chairman of the Board advised the Board that he will not stand for re-election at the Annual Meeting and will retire from the Board at that time.
Role change

Gino Santini

Chairman of the Board
COLL · COLLEGIUM PHARMACEUTICAL, INC
Filed
March 17, 2025, 7:59 PM ET
The Board has named Gino Santini, the Company’s lead independent director since 2018, as Chairman of the Board, effective immediately following the Company’s Annual Meeting.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.9

Carlos Paya was appointed as Director at COLLEGIUM PHARMACEUTICAL, INC.

Action
nominated
Role
Director
Exact text from the filing
approved the nomination of Dr. Carlos Paya to stand for election
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Gwen Melincoff departed as Director at COLLEGIUM PHARMACEUTICAL, INC.

Action
will not stand for re-election and retire
Role
Director
Exact text from the filing
Gwen Melincoff also advised the Board that she will not stand for re-election at the Annual Meeting and will retire from the Board at that time.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Heffernan departed as Chairman of the Board at COLLEGIUM PHARMACEUTICAL, INC.

Action
will not stand for re-election and retire
Role
Chairman of the Board
Exact text from the filing
Michael Heffernan, R.Ph., founder and current Chairman of the Board advised the Board that he will not stand for re-election at the Annual Meeting and will retire from the Board at that time.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Gino Santini changed role as Chairman of the Board at COLLEGIUM PHARMACEUTICAL, INC.

Action
named Chairman of the Board
Role
Chairman of the Board
Exact text from the filing
The Board has named Gino Santini, the Company’s lead independent director since 2018, as Chairman of the Board, effective immediately following the Company’s Annual Meeting.
View on SEC.gov

COLLEGIUM PHARMACEUTICAL, INC filing history →

Source: SEC EDGAR
accession 0001104659-25-024185
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.